Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. Issue 4 (1st September 2022)
- Record Type:
- Journal Article
- Title:
- Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. Issue 4 (1st September 2022)
- Main Title:
- Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET
- Authors:
- Ottoy, Julie
Ozzoude, Miracle
Zukotynski, Katherine
Adamo, Sabrina
Scott, Christopher
Gaudet, Vincent
Ramirez, Joel
Swardfager, Walter
Cogo‐Moreira, Hugo
Lam, Benjamin
Bhan, Aparna
Mojiri, Parisa
Kang, Min Su
Rabin, Jennifer S.
Kiss, Alex
Strother, Stephen
Bocti, Christian
Borrie, Michael
Chertkow, Howard
Frayne, Richard
Hsiung, Robin
Laforce, Robert Jr.
Noseworthy, Michael D.
Prato, Frank S.
Sahlas, Demetrios J.
Smith, Eric E.
Kuo, Phillip H.
Sossi, Vesna
Thiel, Alexander
Soucy, Jean‐Paul
Tardif, Jean‐Claude
Black, Sandra E.
Goubran, Maged
… (more) - Abstract:
- Abstract: It remains unclear to what extent cerebrovascular burden relates to amyloid beta (Aβ) deposition, neurodegeneration, and cognitive dysfunction in mixed disease populations with small vessel disease and Alzheimer's disease (AD) pathology. In 120 subjects, we investigated the association of vascular burden (white matter hyperintensity [WMH] volumes) with cognition. Using mediation analyses, we tested the indirect effects of WMH on cognition via Aβ deposition ( 18 F‐AV45 positron emission tomography [PET]) and neurodegeneration (cortical thickness or 18 F fluorodeoxyglucose PET) in AD signature regions. We observed that increased total WMH volume was associated with poorer performance in all tested cognitive domains, with the strongest effects observed for semantic fluency. These relationships were mediated mainly via cortical thinning, particularly of the temporal lobe, and to a lesser extent serially mediated via Aβ and cortical thinning of AD signature regions. WMH volumes differentially impacted cognition depending on lobar location and Aβ status. In summary, our study suggests mainly an amyloid‐independent pathway in which vascular burden affects cognitive function via localized neurodegeneration. Highlights: Alzheimer's disease often co‐exists with vascular pathology. We studied a unique cohort enriched for high white matter hyperintensities (WMH). High WMH related to cognitive impairment of semantic fluency and executive function. This relationship was mediatedAbstract: It remains unclear to what extent cerebrovascular burden relates to amyloid beta (Aβ) deposition, neurodegeneration, and cognitive dysfunction in mixed disease populations with small vessel disease and Alzheimer's disease (AD) pathology. In 120 subjects, we investigated the association of vascular burden (white matter hyperintensity [WMH] volumes) with cognition. Using mediation analyses, we tested the indirect effects of WMH on cognition via Aβ deposition ( 18 F‐AV45 positron emission tomography [PET]) and neurodegeneration (cortical thickness or 18 F fluorodeoxyglucose PET) in AD signature regions. We observed that increased total WMH volume was associated with poorer performance in all tested cognitive domains, with the strongest effects observed for semantic fluency. These relationships were mediated mainly via cortical thinning, particularly of the temporal lobe, and to a lesser extent serially mediated via Aβ and cortical thinning of AD signature regions. WMH volumes differentially impacted cognition depending on lobar location and Aβ status. In summary, our study suggests mainly an amyloid‐independent pathway in which vascular burden affects cognitive function via localized neurodegeneration. Highlights: Alzheimer's disease often co‐exists with vascular pathology. We studied a unique cohort enriched for high white matter hyperintensities (WMH). High WMH related to cognitive impairment of semantic fluency and executive function. This relationship was mediated via temporo‐parietal atrophy rather than metabolism. This relationship was, to lesser extent, serially mediated via amyloid beta and atrophy. … (more)
- Is Part Of:
- Alzheimer's & dementia. Volume 19:Issue 4(2023)
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 19:Issue 4(2023)
- Issue Display:
- Volume 19, Issue 4 (2023)
- Year:
- 2023
- Volume:
- 19
- Issue:
- 4
- Issue Sort Value:
- 2023-0019-0004-0000
- Page Start:
- 1503
- Page End:
- 1517
- Publication Date:
- 2022-09-01
- Subjects:
- Alzheimer's disease -- amyloid -- biomarker -- cognition -- cortical atrophy -- glucose metabolism -- neurodegeneration -- small vessel disease -- vascular -- white matter disease -- white matter hyperintensities
Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.12750 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26949.xml